The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The acquisition adds HLD-0915, a once-daily oral therapy for prostate cancer, to Johnson & Johnson’s nearly 20-year legacy of innovation in the disease
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
The funding will accelerate Sinopia’s data-driven drug discovery efforts
The primary goal of the collaboration is joint research into trending and next-generation molecules
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
